Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov.
Most participants first33,758 with no events in either group come last2,221 to 2,240 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| HEART Care vs Usual Care: serious adverse events | 345 of 1,821 405 of 1,827 | -3.2 points -5.8 to -0.6 | 3,648 | NCT01756846 Impact on Management of the HEART Risk Score in Chest Pain Patients |
| Metformin vs Placebo: serious adverse events | 1 of 1,816 3 of 1,816 | -0.1 points -0.4 to 0.2 | 3,632 | NCT01101438 A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer |
| Norepinephrine vs Phenylephrine: Rehospitalization Within 30 Days | 56 of 1,809 66 of 1,817 | -0.5 points -1.7 to 0.6 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: Number of Participants With Myocardial Injury After Non-cardiac Surgery (MINS) | 44 of 1,809 38 of 1,817 | 0.3 points -0.6 to 1.3 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: Number of Participants Who Died Within 30 Days After Surgery | 20 of 1,809 22 of 1,817 | -0.1 points -0.8 to 0.6 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: Number of Participants With Severe Acute Kidney Injury | 28 of 1,809 31 of 1,817 | -0.2 points -1.0 to 0.7 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: Number of Participants With Assigned Vasopressor Given | 1,570 of 1,809 1,627 of 1,817 | -2.8 points -4.9 to -0.7 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: Number of Participants With Acute Kidney Injury (AKI) | 140 of 1,809 135 of 1,817 | 0.3 points -1.4 to 2.0 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: deaths from any cause | 20 of 1,809 22 of 1,817 | -0.1 points -0.8 to 0.6 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: Adverse Cardio-renal Events | 168 of 1,809 159 of 1,817 | 0.5 points -1.3 to 2.4 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Norepinephrine vs Phenylephrine: serious adverse events | 20 of 1,809 22 of 1,817 | -0.1 points -0.8 to 0.6 | 3,626 | NCT04789330 Norepinephrine vs Phenylephrine During General Anesthesia |
| Canadian C-Spine Rule vs Control Phase (Usual Care): Proportion of Patients Transported With Spinal Immobilization | 813 of 1,885 1,334 of 1,740 | -33.5 points -36.5 to -30.5 | 3,625 | NCT02786966 A Pragmatic Evaluation of the Canadian C-Spine Rule by Paramedics |
| Intervention Group vs Wait List Control Group: Sustainability of the Intervention Benefit for Completion of the HPV Vaccine. | 1,279 of 2,211 703 of 1,410 | 8.0 points 4.7 to 11.3 | 3,621 | NCT04180462 Increasing Optimal Use of HPV Vaccination in Primary Care |
| Intervention Group vs Wait List Control Group: Sustainability of the Intervention Benefit for Initiation of the HPV Vaccine. | 1,812 of 2,211 1,052 of 1,410 | 7.3 points 4.6 to 10.1 | 3,621 | NCT04180462 Increasing Optimal Use of HPV Vaccination in Primary Care |
| aCRT ON vs aCRT OFF: Percent of Patients With Interventions for Heart Failure Decompensation | 238 of 1,810 255 of 1,807 | -1.0 points -3.2 to 1.3 | 3,617 | NCT02205359 AdaptResponse Clinical Trial |
| aCRT ON vs aCRT OFF: All-cause Mortality | 293 of 1,810 327 of 1,807 | -1.9 points -4.4 to 0.5 | 3,617 | NCT02205359 AdaptResponse Clinical Trial |
| aCRT ON vs aCRT OFF: Atrial Fibrillation | 317 of 1,810 316 of 1,807 | 0.0 points -2.5 to 2.5 | 3,617 | NCT02205359 AdaptResponse Clinical Trial |
| aCRT ON vs aCRT OFF: deaths from any cause | 293 of 1,810 327 of 1,807 | -1.9 points -4.4 to 0.5 | 3,617 | NCT02205359 AdaptResponse Clinical Trial |
| aCRT ON vs aCRT OFF: Combined Endpoint of All-cause Mortality and Intervention for Heart Failure Decompensation | 430 of 1,810 470 of 1,807 | -2.3 points -5.1 to 0.6 | 3,617 | NCT02205359 AdaptResponse Clinical Trial |
| aCRT ON vs aCRT OFF: serious adverse events | 1,072 of 1,810 1,073 of 1,807 | -0.2 points -3.4 to 3.0 | 3,617 | NCT02205359 AdaptResponse Clinical Trial |
Code
curl "https://conductscience.org/api/comparisons/v1?page=112"
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=112
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT01756846-sae",
"title": "HEART Care vs Usual Care: serious adverse events",
"summary": "345 of 1821 against 405 of 1827; risk difference -3.2 points, 95% interval -5.8 to -0.6; NCT01756846, Impact on Management of the HEART Risk Score in Chest Pain Patients",
"record": "/library/comparisons/NCT01756846-sae",
"nct_id": "NCT01756846",
"kind": "serious-adverse-events",
"participants": 3648,
"risk_difference": {
"value": -0.03221853417842738,
"lower": -0.05840101329420018,
"upper": -0.005986831314517525
},
"group_1": "345 of 1,821",
"group_2": "405 of 1,827",
"difference": "-3.2 points",
"interval": "-5.8 to -0.6",
"trial_title": "Impact on Management of the HEART Risk Score in Chest Pain Patients"
},
{
"id": "NCT01101438-sae",
"title": "Metformin vs Placebo: serious adverse events",
"summary": "1 of 1816 against 3 of 1816; risk difference -0.1 points, 95% interval -0.4 to 0.2; NCT01101438, A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer",
"record": "/library/comparisons/NCT01101438-sae",
"nct_id": "NCT01101438",
"kind": "serious-adverse-events",
"participants": 3632,
"risk_difference": {
"value": -0.0011013215859030836,
"lower": -0.004327254854396716,
"upper": 0.0016829110282150705
},
"group_1": "1 of 1,816",
"group_2": "3 of 1,816",
"difference": "-0.1 points",
"interval": "-0.4 to 0.2",
"trial_title": "A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "No license stated"
}
],
"next": "/api/comparisons/v1?page=113",
"request_id": "cwH05gU7HJC1Zw--"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant